OMERS ADMINISTRATION Corp bought a new stake in Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 9,345 shares of the conglomerate's stock, valued at approximately $6,729,000.
Several other hedge funds have also recently added to or reduced their stakes in DHR. BlackRock Inc. acquired a new position in shares of Danaher in the 2nd quarter worth approximately $10,492,520,000. Norges Bank acquired a new stake in Danaher in the 4th quarter valued at $2,177,106,000. Generation Investment Management LLP bought a new stake in Danaher in the second quarter valued at $1,287,949,000. Flossbach Von Storch SE bought a new stake in Danaher in the second quarter valued at $747,260,000. Finally, Bank of New York Mellon Corp acquired a new position in Danaher during the second quarter worth $712,875,000. Institutional investors and hedge funds own 79.05% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on the stock. Guggenheim reduced their target price on shares of Danaher from $235.00 to $200.00 and set a "buy" rating on the stock in a research note on Wednesday, July 22nd. DZ Bank started coverage on shares of Danaher in a research report on Wednesday, June 3rd. They set a "buy" rating and a $210.00 target price for the company. Royal Bank Of Canada lifted their price target on shares of Danaher from $200.00 to $215.00 and gave the company an "outperform" rating in a report on Wednesday, July 22nd. Citigroup began coverage on shares of Danaher in a research note on Tuesday, May 26th. They set a "buy" rating and a $230.00 price objective on the stock. Finally, Wells Fargo & Company dropped their price objective on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating for the company in a report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $228.91.
View Our Latest Research Report on Danaher
Danaher Trading Down 1.7%
DHR opened at $215.18 on Tuesday. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $151.27 billion, a PE ratio of 38.22, a PEG ratio of 2.72 and a beta of 0.78. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The firm has a 50-day moving average price of $196.49 and a two-hundred day moving average price of $192.39.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to analysts' expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher's revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.77 earnings per share. As a group, equities analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.
Danaher Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
